{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:26:03Z","timestamp":1786443963243,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","award":["Subaward No. 5710002350"],"award-info":[{"award-number":["Subaward No. 5710002350"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["KF10-0039"],"award-info":[{"award-number":["KF10-0039"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2020-0261"],"award-info":[{"award-number":["FO2020-0261"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Suicide is a major cause of death worldwide. Several biological systems have been implicated in suicidal behavior but studies of candidate biomarkers have failed to produce clinically relevant biomarkers for suicide prediction. The objective of the present study was to identify novel candidate biomarkers for suicidal behavior. We used a nested case-control study design where a large cohort of patients with bipolar disorder (<jats:italic>N<\/jats:italic>\u2009=\u20095 110) were followed up to 8 years after blood sampling. We included patients that attempted suicide during follow-up (<jats:italic>N<\/jats:italic>\u2009=\u2009348) and matched bipolar disorder patients from the same cohort who did not attempt suicide during the study period (<jats:italic>N<\/jats:italic>\u2009=\u2009348) and analyzed a total of 92 proteins with a neuro exploratory multiplex panel. Using a multivariate classification algorithm devised to minimize bias in variable selection, we identified a parsimonious set of proteins that best discriminated bipolar disorder patients with and without prospective suicide attempts. The algorithm selected 16 proteins for the minimal-optimal classification model, which outperformed 500 models with permuted outcome (<jats:italic>p<\/jats:italic>\u2009=\u20090.0004) but had low sensitivity (53%) and specificity (64%). The candidate proteins were then entered in separate logistic regression models to calculate protein-specific associations with prospective suicide attempts. In individual analyses, three of these proteins were significantly associated with prospective suicide attempt (SCGB1A1, ANXA10, and CETN2). Most of the candidate proteins are novel to suicide research.<\/jats:p>","DOI":"10.1038\/s41380-022-01648-x","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:22:48Z","timestamp":1655119368000},"page":"3857-3863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study"],"prefix":"10.1038","volume":"27","author":[{"given":"Johan V.","family":"Sandberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6738-6495","authenticated-orcid":false,"given":"Caroline","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6118-6054","authenticated-orcid":false,"given":"Andreas","family":"G\u00f6teson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Joas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"P\u00e5lsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-6451","authenticated-orcid":false,"given":"Mikael","family":"Land\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"1648_CR1","unstructured":"World Health Organization. Preventing suicide: A global imperative. 2014."},{"key":"1648_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.170.3.205","volume":"170","author":"EC Harris","year":"1997","unstructured":"Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205\u201328.","journal-title":"Br J Psychiatry"},{"key":"1648_CR3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bdi.12087","volume":"15","author":"M Pompili","year":"2013","unstructured":"Pompili M, Gonda X, Serafini G, Innamorati M, Sher L, Amore M, et al. Epidemiology of suicide in bipolar disorders: A systematic review of the literature. Bipolar Disord. 2013;15:457\u201390.","journal-title":"Bipolar Disord"},{"key":"1648_CR4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","volume":"58","author":"U \u00d6sby","year":"2001","unstructured":"\u00d6sby U, Brandt L, Correia N, Ekbom A, Spar\u00e9n P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844\u201350.","journal-title":"Arch Gen Psychiatry"},{"key":"1648_CR5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/13811110590929488","volume":"9","author":"J Angst","year":"2005","unstructured":"Angst J, Angst F, Gerber-Werder R, Gamma A. Suicide in 406 mood-disorder patients with and without long-term medication: A 40 to 44 years\u2019 follow-up. Arch Suicide Res. 2005;9:279\u2013300.","journal-title":"Arch Suicide Res"},{"key":"1648_CR6","doi-asserted-by":"crossref","first-page":"f3646","DOI":"10.1136\/bmj.f3646","volume":"346","author":"A Cipriani","year":"2013","unstructured":"Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 2013;346:f3646.","journal-title":"BMJ"},{"key":"1648_CR7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/appi.ajp.2017.16050542","volume":"174","author":"J Song","year":"2017","unstructured":"Song J, Sj\u00f6lander A, Joas E, Bergen SE, Runeson B, Larsson H, et al. Suicidal behavior during lithium and valproate treatment: A within-individual 8-year prospective study of 50,000 patients with bipolar disorder. Am J Psychiatry. 2017;174:795\u2013802.","journal-title":"Am J Psychiatry"},{"key":"1648_CR8","unstructured":"SBU. Instrument f\u00f6r bed\u00f6mning av suicidrisk. En systematisk litteratur\u00f6versikt. Stockholm: Statens beredning f\u00f6r medicinsk och social utv\u00e4rdering (SBU) SBU-rapport nr 242. 2015."},{"key":"1648_CR9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/acps.12946","volume":"138","author":"C Hansson","year":"2018","unstructured":"Hansson C, Joas E, P\u00e5lsson E, Hawton K, Runeson B, Land\u00e9n M. Risk factors for suicide in bipolar disorder: A cohort study of 12 850 patients. Acta Psychiatr Scand. 2018;138:456\u201363.","journal-title":"Acta Psychiatr Scand"},{"key":"1648_CR10","doi-asserted-by":"crossref","first-page":"e94097","DOI":"10.1371\/journal.pone.0094097","volume":"9","author":"D Tidemalm","year":"2014","unstructured":"Tidemalm D, Haglund A, Karanti A, Land\u00e9n M, Runeson B. Attempted suicide in bipolar disorder: risk factors in a cohort of 6086 patients. PLoS One. 2014;9:e94097.","journal-title":"PLoS One"},{"key":"1648_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1037\/bul0000084","volume":"143","author":"JC Franklin","year":"2017","unstructured":"Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, Huang X, et al. Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research. Psychol Bull. 2017;143:187\u2013232.","journal-title":"Psychol Bull"},{"key":"1648_CR12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamapsychiatry.2019.0174","volume":"76","author":"BE Belsher","year":"2019","unstructured":"Belsher BE, Smolenski DJ, Pruitt LD, Bush NE, Beech EH, Workman DE, et al. Prediction models for suicide attempts and deaths: A systematic review and simulation. JAMA Psychiatry. 2019;76:642\u201351.","journal-title":"JAMA Psychiatry"},{"key":"1648_CR13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archpsyc.1976.01770100055005","volume":"33","author":"M \u00c5sberg","year":"1976","unstructured":"\u00c5sberg M, Tr\u00e4skman L, Thor\u00e9n P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor. Arch Gen Psychiatry. 1976;33:1193\u20137.","journal-title":"Arch Gen Psychiatry"},{"key":"1648_CR14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/mp.2017.141","volume":"22","author":"P-E Lutz","year":"2017","unstructured":"Lutz P-E, Mechawar N, Turecki G. Neuropathology of suicide: Recent findings and future directions. Mol Psychiatry. 2017;22:1395\u2013412.","journal-title":"Mol Psychiatry"},{"key":"1648_CR15","doi-asserted-by":"crossref","unstructured":"Lengvenyte A, Conejero I, Courtet P, Oli\u00e9 E. Biological bases of suicidal behaviours: A narrative review. Eur J Neurosci. 2021;53:330\u201351.","DOI":"10.1111\/ejn.14635"},{"key":"1648_CR16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/acps.12458","volume":"132","author":"L Brundin","year":"2015","unstructured":"Brundin L, Erhardt S, Bryleva EY, Achtyes ED, Postolache TT. The role of inflammation in suicidal behaviour. Acta Psychiatr Scandinavica. 2015;132:192\u2013203.","journal-title":"Acta Psychiatr Scandinavica"},{"key":"1648_CR17","doi-asserted-by":"crossref","unstructured":"Eisen RB, Perera S, Banfield L, Anglin R, Minuzzi L, Samaan Z. Association between BDNF levels and suicidal behaviour: A systematic review and meta-analysis. Sys. Rev. 2015;4:187.","DOI":"10.1186\/s13643-015-0179-z"},{"key":"1648_CR18","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.165","volume":"6","author":"BP Chang","year":"2016","unstructured":"Chang BP, Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, et al. Biological risk factors for suicidal behaviors: A meta-analysis. Transl Psychiatry. 2016;6:e887.","journal-title":"Transl Psychiatry"},{"key":"1648_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/srep25229","volume":"6","author":"RB Eisen","year":"2016","unstructured":"Eisen RB, Perera S, Bawor M, Dennis BB, El-Sheikh W, DeJesus J, et al. Exploring the Association between Serum BDNF and Attempted Suicide. Sci Rep. 2016;6:25229.","journal-title":"Sci Rep"},{"key":"1648_CR20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/appi.ajp.2014.14020194","volume":"171","author":"MA Oquendo","year":"2014","unstructured":"Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME, et al. Toward a biosignature for suicide. Am J Psychiatry. 2014;171:1259\u201377.","journal-title":"Am J Psychiatry"},{"key":"1648_CR21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1542\/peds.2012-0469","volume":"131","author":"SB Johnson","year":"2013","unstructured":"Johnson SB, Riley AW, Granger DA, Riis J. The science of early life toxic stress for pediatric practice and advocacy. Pediatrics 2013;131:319\u201327.","journal-title":"Pediatrics"},{"key":"1648_CR22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/mp.2013.95","volume":"18","author":"H Le-Niculescu","year":"2013","unstructured":"Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, et al. Discovery and validation of blood biomarkers for suicidality. Mol psychiatry. 2013;18:1249.","journal-title":"Mol psychiatry"},{"key":"1648_CR23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41588-019-0397-8","volume":"51","author":"EA Stahl","year":"2019","unstructured":"Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51:793\u2013803.","journal-title":"Nat Genet"},{"key":"1648_CR24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1600-0447.2011.01747.x","volume":"124","author":"C Sellgren","year":"2011","unstructured":"Sellgren C, Land\u00e9n M, Lichtenstein P, Hultman CM, L\u00e5ngstr\u00f6m N. Validity of bipolar disorder hospital discharge diagnoses: File review and multiple register linkage in Sweden. Acta Psychiatr Scand. 2011;124:447\u201353.","journal-title":"Acta Psychiatr Scand"},{"key":"1648_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim J-L, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC public health. 2011;11:450.","journal-title":"BMC public health"},{"key":"1648_CR26","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bj\u00f6rkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9:e95192.","journal-title":"PLoS One"},{"key":"1648_CR27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/bioinformatics\/bty710","volume":"35","author":"L Shi","year":"2019","unstructured":"Shi L, Westerhuis JA, Ros\u00e9n J, Landberg R, Brunius C. Variable selection and validation in multivariate modelling. Bioinformatics 2019;35:972\u201380.","journal-title":"Bioinformatics"},{"key":"1648_CR28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/cem.785","volume":"17","author":"M Barker","year":"2003","unstructured":"Barker M, Rayens W. Partial least squares for discrimination. J Chemometrics: A J Chemometrics Soc. 2003;17:166\u201373.","journal-title":"J Chemometrics: A J Chemometrics Soc"},{"key":"1648_CR29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.chemolab.2012.07.010","volume":"118","author":"T Mehmood","year":"2012","unstructured":"Mehmood T, Liland KH, Snipen L, S\u00e6b\u00f8 S. A review of variable selection methods in Partial Least Squares Regression. Chemometrics Intell Lab Syst. 2012;118:62\u201369.","journal-title":"Chemometrics Intell Lab Syst"},{"key":"1648_CR30","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. Royal Stat. 1995;57:289\u2013300.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"1648_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-1781(01)00338-9","volume":"105","author":"W Rief","year":"2001","unstructured":"Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res. 2001;105:165\u201374.","journal-title":"Psychiatry Res"},{"key":"1648_CR32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0924-977X(01)00081-5","volume":"11","author":"O Mikova","year":"2001","unstructured":"Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol. 2001;11:203\u20138.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1648_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0165-1781(99)00012-8","volume":"85","author":"C Song","year":"1999","unstructured":"Song C, Kenis G, van Gastel A, Bosmans E, Lin A, de Jong R, et al. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res. 1999;85:293\u2013303.","journal-title":"Psychiatry Res"},{"key":"1648_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0920-9964(96)00029-1","volume":"21","author":"M Maes","year":"1996","unstructured":"Maes M, Bosmans E, Ranjan R, Vandoolaeghe E, Meltzer HY, De Ley M, et al. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophr Res. 1996;21:39\u201350.","journal-title":"Schizophr Res"},{"key":"1648_CR35","first-page":"385","volume":"1","author":"I Dierynck","year":"1996","unstructured":"Dierynck I, Bernard A, Roels H, DeLey M. The human Clara cell protein: Biochemical and biological characterisation of a natural immunosuppressor. Multiple Sclerosis. Journal 1996;1:385\u20137.","journal-title":"Journal"},{"key":"1648_CR36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4613-0651-1_9","volume":"279","author":"L Miele","year":"1990","unstructured":"Miele L, Cordella-Miele E, Facchiano A, Mukherjee AB. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides. Adv Exp Med Biol. 1990;279:137\u201360.","journal-title":"Adv Exp Med Biol"},{"key":"1648_CR37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/acschemneuro.5b00073","volume":"6","author":"WY Ong","year":"2015","unstructured":"Ong WY, Farooqui T, Kokotos G, Farooqui AA. Synthetic and natural inhibitors of phospholipases A2: Their importance for understanding and treatment of neurological disorders. ACS Chem Neurosci. 2015;6:814\u201331.","journal-title":"ACS Chem Neurosci"},{"key":"1648_CR38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","volume":"61","author":"SI Rapoport","year":"2009","unstructured":"Rapoport SI, Basselin M, Kim HW, Rao JS. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009;61:185\u2013209.","journal-title":"Brain Res Rev"},{"key":"1648_CR39","doi-asserted-by":"crossref","unstructured":"Schloer S, Pajonczyk D, Rescher U. Annexins in translational research: Hidden treasures to be found. Int J Mol Sci. 2018;19:1781.","DOI":"10.3390\/ijms19061781"},{"key":"1648_CR40","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms14022652","volume":"14","author":"MA Lizarbe","year":"2013","unstructured":"Lizarbe MA, Barrasa JI, Olmo N, Gavilanes F, Turnay J. Annexin-phospholipid interactions. Funct Implic Int J Mol Sci. 2013;14:2652\u201383.","journal-title":"Funct Implic Int J Mol Sci"},{"key":"1648_CR41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0960-9822(02)01019-9","volume":"12","author":"JL Salisbury","year":"2002","unstructured":"Salisbury JL, Suino KM, Busby R, Springett M. Centrin-2 is required for centriole duplication in mammalian cells. Curr Biol. 2002;12:1287\u201392.","journal-title":"Curr Biol"},{"key":"1648_CR42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1083\/jcb.201411070","volume":"208","author":"SL Prosser","year":"2015","unstructured":"Prosser SL, Morrison CG. Centrin2 regulates CP110 removal in primary cilium formation. J Cell Biol. 2015;208:693\u2013701.","journal-title":"J Cell Biol"},{"key":"1648_CR43","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/MCB.25.13.5664-5674.2005","volume":"25","author":"R Nishi","year":"2005","unstructured":"Nishi R, Okuda Y, Watanabe E, Mori T, Iwai S, Masutani C, et al. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein. Mol Cell Biol. 2005;25:5664\u201374.","journal-title":"Mol Cell Biol"},{"key":"1648_CR44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4306\/pi.2015.12.3.388","volume":"12","author":"L Gao","year":"2015","unstructured":"Gao L, Gao Y, Xu E, Xie J. Microarray analysis of the major depressive disorder mRNA profile data. Psychiatry Investig. 2015;12:388\u201396.","journal-title":"Psychiatry Investig"},{"issue":"Suppl 1","key":"1648_CR45","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/j.psyneuen.2009.05.021","volume":"34","author":"EB Binder","year":"2009","unstructured":"Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009;34(Suppl 1):S186\u201395.","journal-title":"Psychoneuroendocrinology"},{"key":"1648_CR46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.mp.4002141","volume":"14","author":"VL Willour","year":"2009","unstructured":"Willour VL, Chen H, Toolan J, Belmonte P, Cutler DJ, Goes FS, et al. Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry. 2009;14:261\u20138.","journal-title":"Mol Psychiatry"},{"key":"1648_CR47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","volume":"36","author":"EB Binder","year":"2004","unstructured":"Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, P\u00fctz B, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36:1319\u201325.","journal-title":"Nat Genet"},{"key":"1648_CR48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.299.11.1291","volume":"299","author":"EB Binder","year":"2008","unstructured":"Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008;299:1291\u2013305.","journal-title":"JAMA"},{"key":"1648_CR49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.psyneuen.2012.11.008","volume":"38","author":"JM P\u00e9rez-Ortiz","year":"2013","unstructured":"P\u00e9rez-Ortiz JM, Garc\u00eda-Guti\u00e9rrez MS, Navarrete F, Giner S, Manzanares J. Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology 2013;38:1251\u20138.","journal-title":"Psychoneuroendocrinology"},{"key":"1648_CR50","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1176\/appi.ajp.2009.09040576","volume":"167","author":"D Brent","year":"2010","unstructured":"Brent D, Melhem N, Ferrell R, Emslie G, Wagner KD, Ryan N, et al. Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry. 2010;167:190\u20137.","journal-title":"Am J Psychiatry"},{"key":"1648_CR51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000441659","volume":"72","author":"S Fudalej","year":"2015","unstructured":"Fudalej S, Kopera M, Wo\u0142y\u0144czyk-Gmaj D, Fudalej M, Krajewski P, Wasilewska K, et al. Association between FKBP5 functional polymorphisms and completed suicide. Neuropsychobiology 2015;72:126\u201331.","journal-title":"Neuropsychobiology"},{"key":"1648_CR52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pnpbp.2010.11.019","volume":"35","author":"I Supriyanto","year":"2011","unstructured":"Supriyanto I, Sasada T, Fukutake M, Asano M, Ueno Y, Nagasaki Y, et al. Association of FKBP5 gene haplotypes with completed suicide in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:252\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1648_CR53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fphar.2019.00060","volume":"10","author":"Z Deng","year":"2019","unstructured":"Deng Z, Deng S, Zhang MR, Tang MM. Fibroblast growth factors in depression. Front Pharm. 2019;10:60.","journal-title":"Front Pharm"},{"key":"1648_CR54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuron.2012.08.037","volume":"76","author":"C Turner","year":"2012","unstructured":"Turner C, Watson S, Akil H. The fibroblast growth factor family: Neuromodulation of affective behavior. Neuron 2012;76:160\u201374.","journal-title":"Neuron"},{"key":"1648_CR55","doi-asserted-by":"crossref","first-page":"15506","DOI":"10.1073\/pnas.0406788101","volume":"101","author":"SJ Evans","year":"2004","unstructured":"Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H, et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA. 2004;101:15506\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1648_CR56","doi-asserted-by":"crossref","first-page":"11953","DOI":"10.1073\/pnas.1510456112","volume":"112","author":"EL Aurbach","year":"2015","unstructured":"Aurbach EL, Inui EG, Turner CA, Hagenauer MH, Prater KE, Li JZ, et al. Fibroblast growth factor 9 is a novel modulator of negative affect. Proc Natl Acad Sci USA. 2015;112:11953\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1648_CR57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pneurobio.2009.09.001","volume":"89","author":"C Ernst","year":"2009","unstructured":"Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol. 2009;89:315\u201333.","journal-title":"Prog Neurobiol"},{"key":"1648_CR58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ynstr.2018.02.002","volume":"8","author":"A Polacchini","year":"2018","unstructured":"Polacchini A, Girardi D, Falco A, Zanotta N, Comar M, De Carlo NA, et al. Distinct CCL2, CCL5, CCL11, CCL27, IL-17, IL-6, BDNF serum profiles correlate to different job-stress outcomes. Neurobiol Stress. 2018;8:82\u201391.","journal-title":"Neurobiol Stress"},{"key":"1648_CR59","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/acs.jproteome.9b00320","volume":"18","author":"JR Daniels","year":"2019","unstructured":"Daniels JR, Cao Z, Maisha M, Schnackenberg LK, Sun J, Pence L, et al. Stability of the human plasma proteome to pre-analytical variability as assessed by an aptamer-based approach. J Proteome Res. 2019;18:3661\u201370.","journal-title":"J Proteome Res"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01648-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01648-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01648-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:25:06Z","timestamp":1680863106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01648-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1038\/s41380-022-01648-x","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ML reports that he has received lecture honoraria from Lundbeck pharmaceuticals. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}